Skip to content
Trial Eligibility
Menu

Natural History Study of Mitochondrial Myopathy

NCT05250375

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this observational study is to develop and validate tools to measure disease course in patients with primary mitochondrial myopathy (PMM). The main aims of this study are: Development, validation, and optimization of objective outcome measures for mitochondrial myopathy Defining the natural history of mitochondrial myopathy Researchers will compare data from patients with primary mitochondrial myopathy to healthy controls. Data from healthy controls will also help define normative data for future studies.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Primary Mitochondrial Disease

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
0 to 100 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Children's Hospital of Philadelphia
Last updated on ClinicalTrials.gov
September 17, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Pennsylvania · 1

  • Children's Hospital of Philadelphia · Philadelphia, PA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.